Recognized in Best Lawyers since 2023 
Emer Simic is a partner in the Intellectual Property Practice Group and focuses her practice on patent litigation and counseling in the pharmaceutical and biotech space. Emer has substantial experience successfully representing pharmaceutical and biotech companies in Hatch-Waxman and patent infringement disputes before the U.S. District Court and before the Patent Trial and Appeal Board (PTAB). A strategic advisor and compelling advocate, Emer partners with her clients to achieve their goals at all phases of litigation, from pre-litigation counseling and opinions through FDA filings, discovery, trial and appeal.
Emer's ability to harmonize scientific knowledge with her legal acumen outside the courtroom enables her to effectively counsel her clients on complex IP matters throughout the product lifecycle, from advising on patent prosecution strategy and portfolio management to providing opinions on validity and FTO. Emer also assists with due diligence investigations for pharmaceutical mergers and acquisitions. Building and maintaining robust client relationships is a cornerstone of her practice, aiding businesses through informed decision-making that aligns with her client’s strategic objectives.
Originally from Ireland, Emer also holds the distinction of being a qualified barrister. Within the legal community, she is highly lauded for her accomplishments: listed in Intellectual Asset Management's (IAM) Patent 1000 for Litigation, named among the top "40 Under 40 Illinois Attorneys to Watch" by the Chicago Daily Law Bulletin, honored as one of "Chicago's Notable Women Lawyers" by Crain's Custom Media, and designated an "IP Star" by Managing IP.
